Evaluation of Treatments and Services Provided to People with Duchenne Muscular Dystrophy (DMD)
ArchivedCenters for Disease Control and Prevention - ERA
Description
The purpose of this project is to systematically evaluate agreement between treatments and services actually provided to people who have Duchenne muscular dystrophy (DMD) and current treatment recommendations as documented in the DMD Care Considerations. The evaluation will focus on a limited geographic area (such as one or more states) but the design and results of the study should apply to other geographic areas.
Who can apply
- Others
Contact
CDC <br/>Procurement and Grants Office <br/>TIMS <br/>Phone 770-488-2700
PGOTIM@cdc.gov
- PostedDec 11, 2012
- ClosesFeb 20, 2013
- Award floor$0
- Award ceiling$150,000
- Program funding$550,000
- Expected awards1
- CFDA93.283
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro